Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it. The COVID-19 virus has been named “SARS-CoV-2” (severe acute respiratory syndrome coronavirus 2) and the disease it causes has been named “Coronavirus Disease 2019” (COVID-19). The outbreak of the respiratory disease was first detected in Wuhan City, Hubei Province, China in Dec 2019. Life sciences companies are putting all of their efforts into finding a treatment or developing a vaccine for this disease. PharmaShots is keeping a track of all of the important updates in the Life-sciences sector, where we have covered news updates regarding collaborations, clinical trials, funding, and regulatory guidelines related to the COVID-19 from Jan to date.
Jul 30, 2020 | Clinical Trial
74. Sanofi and GSK Sign an Agreement with the UK Government to Supply ~60M Doses of COVID-19 Vaccine
Jul 29, 2020 | Collaboration
73. UK’s Recovery Continues to Test Roche’s Tocilizumab in COVID-19
Jul 29, 2020 | Clinical Trial
72. Roche’s Actemra/RoActemra Fails in COVID-19 Trial
Jul 29, 2020 | Clinical Trial
71. Green Cross’ GC5131A Receives the Regulatory Approval for P-II Trial for COVID-19
Jul 29, 2020 | Regulatory
Jul 29, 2020 | Regulatory
Jul 28, 2020 | Regulatory
Jul 28, 2020 | Clinical Trial
Jul 28, 2020 | Regulatory
66. Three Pharma Companies Launch Favipiravir to Treat COVID-19 in India
Jul 27, 2020 | Launch
Jul 27, 2020 | Collaboration
Jul 27, 2020 | Clinical Trial
63. Zydus to Initiate Clinical Study of Desidustat in Patients with Chemotherapy-Induced Anemia (CIA)
July 24, 2020 | Clinical Trial
Jul 27, 2020 | Clinical Trial
61. The UK Government to Launch AbC-19 Lateral Flow Free Finger-Prick Test for COVID-19
Jul 27, 2020 | Launch
60. Mylan Launches Remdesivir Under the Brand Name Desrem for COVID-19 in India
Jul 27, 2020 | Launch
59. Pfizer and BioNTech Elicits Strong T-cell Response in P-I/II Study Against COVID-19
Jul 27, 2020 | Clinical Trial
Jul 27, 2020 | Clinical Trial
57. Quest Diagnostic Receives the US FDA’s First EUA for Sample Pooling in COVID-19
Jul 20, 2020 | Diagnostic
56. Celltrion Initiates P-I Study of its COVID-19 Antibody Treatment in South Korea
Jul 20, 2020 | Clinical Trial
55. Zydus Initiates Adaptive P-I/II Clinical Study Evaluating its ZyCoV-D Against COVID-19 in India
Jul 16, 2020 | Clinical Trial
54. Novartis Launches Zero Profit Portfolio for Symptomatic Treatment of COVID-19
Jul 16, 2020 | Launch
53. AstraZeneca and the University of Oxford to Share Positive News on its COVID-19 Vaccine Imminently
Jul 15, 2020 | Collaboration
52. 3M Collaborates with MIT to Develop Paper-Based Diagnostic Test for COVID-19
Jul 13, 2020 | Collaboration
51. Moderna to Commence Late-stage COVID-19 Vaccine Trial on 27 July, 2020
Jul 13, 2020 | Clinical Trial
50. The International Fencing Federation (FIE) Reports the Global COVID-19 Support Plan
July 13, 2020 | Launch
Jul 12, 2020 | Regulatory
48. The Zimbabwe Government to Launch US $10M COVID-19 Relief Package
Jul 11, 2020 | Launch
Jul 10, 2020 | Regulatory
46. AstraZeneca Collaborates with ProteinQure to Design Novel Peptide Therapeutics
Jul 10, 2020 | Collaboration
45. Cipla Launches Cipremi at $53.34 per Vial in India
Jul 10, 2020 | Launch
44. The Health Ministry of Kyrgyzstan Reports Supply of Avifavir an Antiviral Drug form Russia
Jul 09, 2020 | Regulatory
43. Regeneron Signs an Agreement with BARDA and the US Department of Defense for REGN-COV2 Worth $450M
Jul 08, 2020 | Clinical Trial
Jul 08, 2020 | Clinical Trial
Jul 09, 2020 | Collaboration
40. GSK and Medicago to Initiate P-I Trial of Plant-Based COVID-19 Vaccine in July 2020
Jul 08, 2020 | Clinical Trial
39. Regeneron Signs an Agreement with BARDA and the US Department of Defense for REGN-COV2 Worth $450M
Jul 08, 2020 | Collaboration
38. Innovation Pharmaceuticals Reports Results Brilacidin in COVID-19 Clinical Trial
Jul 07, 2020 | Clinical Trial
37. Reven Reports Publication of Two COVID-19 Articles for RJX Platform
Jul 07, 2020 | Regulatory
Jul 07, 2020 | Collaboration
35. Constant Therapeutics’ TXA127 will be Evaluated in P-II Trial for COVID-19 Patients
Jul 07, 2020 | Clinical Trial
34. Sinovac’s P-III COVID-19 Trial Receives the Brazilian Regulator Approval
Jul 07, 2020 | Regulatory
33. Nasus Pharma Reports Results of TaffiX as a Intranasal Antiviral Protection Against SARS-CoV-2
Jul 07, 2020 | Clinical Trial
32. Mylan Receives EUA Approval for its Remdesivir to Treat COVID-19
Jul 07, 2020 | Regulatory
Jul 07, 2020 | Clinical Trial
30. Novavax to Receive $1.6B Funds from the US
Jul 07, 2020 | Grants
29. Aboundbio Signs an Agreement with SaudiVax for COVID-19
Jul 07, 2020 | Collaboration
28. Hepion Pharmaceuticals Reports Preclinical Results of CRV431 for Treating COVID-19
Jul 07, 2020 | Clinical Trial
Jul 07, 2020 | Clinical Trial
Jul 06, 2020 | Clinical Trial
Jul 06, 2020 | Regulatory
24. Zydus to Initiate Clinical Trials Evaluating ZyCoV-D Vaccine Against COVID-19 in July 2020
Jul 03, 2020 | Clinical Trial
23. Sanofi and Regeneron’s Kevzara (sarilumab) Fails in P-III Trial for Patients with COVID-19 in the US
Jul 03, 2020 | Clinical Trial
22. Moderna Reports the Enrollment of P-II Trial for its mRNA-1273 to Treat COVID-19
Jul 03, 2020 | Clinical Trial
21. Sorrento Selects T-VIVA-19 as a Targeted Protein Vaccine Candidate Against COVID-19
Jul 02, 2020 | Clinical Trial
Jul 02, 2020 | Collaboration
19. Pfizer and BioNTech Report Results of BNT162b1 mRNA-Based Vaccine in P-I/II Study Against COVID-19
Jul 02, 2020 | Clinical Trial
18. Zydus to Initiate Clinical Trials Evaluating ZyCoV-D Vaccine Against COVID-19 in July 2020
Jul 03, 2020 | Clinical Trial
17. Sanofi and Regeneron’s Kevzara (sarilumab) Fails in P-III Study for Patients with COVID-19 in the US
Jul 02, 2020 | Clinical Trial
16. Phase II Study of MRx-4DP0004 in Patients Hospitalized with COVID-19 Open for Enrolment
Jul 02, 2020 | Clinical Trial
15. Regulatory Authorities Step Up Cooperation in Connection with COVID-19
Jul 02, 2020 | Regulatory
14. Austria Donates €2M to CEPI to Support COVID-19 Vaccine Programmes
Jul 02, 2020 | Grant
13. Liminal BioSciences Joins CoVIg Plasma Alliance to Develop New COVID-19 Therapy
Jul 02, 2020 | Collaboration
Jul 02, 2020 | Clinical Trial
Jul 02, 2020 | Clinical Trial
10. Moderna Faces Delay in its COVID-19 Vaccine Trial
Jul 02, 2020 | Clinical Trial
9. Anivive Initiates Two Pre-Clinical Studies of GC376 for the Treatment of COVID-19
Jul 02, 2020 | Clinical Trial
Jul 01, 2020 | Clinical Trial
7. GoldenBiotech’s Antroquinonol Receives FDA Approval on COVID-19 P-II Trial in the US
Jul 01, 2020 | Regulatory
6. New Study Highlights Senhwa Biosciences Silmitasertib as Potential Treatment for COVID-19
Jul 01, 2020 | Clinical Trial
5. International Regulators Provide Guiding Principles for COVID-19 Clinical Trials
Jul 01, 2020 | Regulatory
4. FibroGenesis Identifies Mechanism Responsible for Blocking COVID19-Like Lung Inflammation
Jul 01, 2020 | Clinical Trial
3. Inimmune Awarded $2M SBIR to Advance Vaccine Technologies
Jul 01, 2020 | Grant
Jul 01, 2020 | Clinical Trial
1. FAMHP Facilitates and Supports the Development of COVID-19 Treatments and Vaccines
Jul 01, 2020 | Regulatory
Related Post : Insights+ Exclusive: COVID-19 Healthcare News Monthly Updates – June 2020